Cabaletta Bio, Inc. (CABA)
2.94
-0.10
(-3.29%)
USD |
NASDAQ |
Mar 20, 16:00
3.00
+0.06
(+2.04%)
After-Hours: 20:00
Cabaletta Bio Market Cap : 283.02M for March 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Anavex Life Sciences Corp. | 376.25M |
| ACADIA Pharmaceuticals, Inc. | 3.536B |
| Alnylam Pharmaceuticals, Inc. | 41.40B |
| Savara, Inc. | 1.015B |
| BioMarin Pharmaceutical, Inc. | 10.41B |
Market Cap Related Metrics
| PEG Ratio | -0.0676 |
| Price to Book Value | 2.029 |
| Price | 2.94 |
| Earnings Yield | -85.93% |
| PEGY Ratio | -0.0676 |